- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 63.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 63.39M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $49.98M |
| Capex | Q1 2026 · Mar 31, 2025 | $55.48M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $62.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $50.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $126.9M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $123.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.57B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.57B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.55B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.55B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $259.99M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $293.9M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $359.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $369.28M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.27B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.3B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $3.21B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.09 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $58.13M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $56.49M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5.54M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $4.86M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $3.14M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $308.93M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $280.45M |
| Revenue | Q1 2026 · Mar 31, 2026 | $457.33M |
| Revenue | Q1 2026 · Mar 31, 2025 | $417.1M |